logoTry Persana

AOA Dx - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about AOA Dx including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

AOA Dx company logo

Transforming Women’s Health with Breakthrough Cancer Diagnostics and AI

AOA Dx is leading a revolutionary breakthrough in early-stage cancer detection for women, leveraging AI and proprietary biomarker technology to set a new gold standard in early cancer diagnostics.

HeadquartersDenver, CO, United States
Team size51-100
Founded2020

What is AOA Dx? - Company Overview & Details

AOA Dx is AOA Dx is leading a revolutionary breakthrough in early-stage cancer detection for women, leveraging AI and proprietary biomarker technology to set a new gold standard in early cancer diagnostics. Founded in 2020, the company is headquartered in Denver, CO, United States.

Who Founded AOA Dx?

AOA Dx was founded by Oriana Papin-Zoghbi.

Who are the Key Executives at AOA Dx? - Leadership Team

AOA Dx is led by experienced executives in key positions:

Chief Executive Officer (CEO) of AOA Dx

Oriana Papin-ZoghbiCEO

Chief Technology Officer (CTO) of AOA Dx

CTO

About Oriana Papin-Zoghbi - CEO of AOA Dx

Oriana Papin-Zoghbi serves as the Chief Executive Officer of AOA Dx, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

AOA Dx Company Details & Key Information

Where is AOA Dx located?

AOA Dx is headquartered in Denver, CO, United States.

How many employees does AOA Dx have?

AOA Dx has 51-100 employees.

When was AOA Dx founded?

AOA Dx was founded in 2020.

AOA Dx Official Website

How much funding has AOA Dx raised?

AOA Dx has raised $24 Million across 5 funding rounds. The most recent funding was completed on 2023-11-11.

Funding Overview

AOA Dx has successfully raised a total of $24 million to advance its ovarian cancer diagnostic test and expand lab facilities.

$24 Million
Total Funding Raised
5
Funding Rounds
2023-11-11
Latest Round

AOA Dx Funding History

Series A
2023-11-11
$17 Million
Series unknown
2023-11-11
$17 Million

Who are the key investors in AOA Dx?

AOA Dx is backed by 1 key investors including Good Growth Capital. These investors focus on Biotechnology, Healthcare sectors.

AOA Dx Investor Overview

1
Key Investors
2
Focus Areas
0
Notable Investments

Complete List of AOA Dx Investors

Good Growth Capital

An investment firm focused on funding innovative companies in the growth stage.

Investment Focus
Biotechnology
Healthcare

What sectors do AOA Dx investors focus on?

The investors backing AOA Dx primarily focus on Biotechnology, Healthcare sectors.

Biotechnology
Healthcare

Featured Investor: Good Growth Capital

Good Growth Capital

An investment firm focused on funding innovative companies in the growth stage.

Notable Investments:

What are AOA Dx's future plans?

AOA Dx Continue advancing the development of its ovarian cancer diagnostic test and expand lab capabilities.

AOA Dx Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does AOA Dx face?

AOA Dx has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for AOA Dx

1

Market competition

2

Regulatory approvals

What opportunities does AOA Dx have?

AOA Dx has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for AOA Dx

1

Growing demand for women's health diagnostics

2

Expansion into additional cancer diagnostics

AOA Dx Strategic Position Summary

Key Focus Areas

AOA Dx is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about AOA Dx?

AOA Dx has 2 recent news updates covering key business developments and market activities.

AOA Dx News Overview

2
Recent Articles
Active
Media Coverage
2025-05-05
Latest Update

What is AOA Dx in the news for?

AOA Dx is currently featured in news for AOA Dx Inc attends event 2025 American Association for Cancer Research Annual Meeting. and other significant business developments.

Recent News Articles About AOA Dx

Article 1
2025-05-05

AOA Dx Inc attends event 2025 American Association for Cancer Research Annual Meeting.

AOA Dx has demonstrated high accuracy in detecting ovarian cancer using its AI-powered multi-omic platform.

femtechinsider.com
Read News
Article 2
2025-05-21

Sonraí Analytics Ltd partners with AOA Dx Inc.

Sonrai Analytics partners with AOA Dx to enhance ovarian cancer testing through AI-driven diagnostics.

irishnews.com
Read News

AOA Dx FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about AOA Dx including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

AOA Dx Questions & Answers - Company Information

Q1

What is AOA Dx?

AOA Dx is leading a revolutionary breakthrough in early-stage cancer detection for women, leveraging AI and proprietary biomarker technology to set a new gold standard in early cancer diagnostics.

Q2

Who founded AOA Dx?

AOA Dx was founded by Oriana Papin-Zoghbi.

Q3

Who is the CEO of AOA Dx?

The CEO of AOA Dx is Oriana Papin-Zoghbi. You can find more information about them on their LinkedIn profile.

Q4

How much funding has AOA Dx raised?

AOA Dx has raised a total of $$24 Million across 5 funding rounds. The most recent funding was completed on 2023-11-11.

Q5

Who are the investors in AOA Dx?

AOA Dx's key investors include Good Growth Capital.

Q6

Where is AOA Dx headquartered?

AOA Dx is headquartered in Denver, CO, United States.

Q7

When was AOA Dx founded?

AOA Dx was founded in 2020.

Q8

How many employees does AOA Dx have?

AOA Dx has 51-100 employees.

Q9

What is AOA Dx's official website?

You can visit AOA Dx's official website at http://www.aoadx.com.

Q10

What was AOA Dx's latest funding round?

AOA Dx's latest funding round was a Series A round of $$17 Million completed on 2023-11-11.

Q11

Who is founder?

Oriana Papin-Zoghbi

Q12

What does the company do?

AOA Dx develops innovative blood-based diagnostics for early cancer detection, focusing on ovarian cancer.

Q13

How much funding?

$24 Million

Q14

Latest funding date?

2023-11-11

Q15

Who are the investors?

Good Growth Capital

Q16

What are the challenges?

Market competition Regulatory approvals

Q17

What are the opportunities?

Growing demand for women's health diagnostics Expansion into additional cancer diagnostics

Q18

Latest news?

AOA Dx has demonstrated high accuracy in detecting ovarian cancer using its AI-powered multi-omic platform. Sonrai Analytics partners with AOA Dx to enhance ovarian cancer testing through AI-driven diagnostics.

More Information About AOA Dx

For additional details about AOA Dx, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.